Effect of hyperthermia and X-irradiation on survival and occurrence of metastases in mice bearing P388 tumor.
Survival of P388 lymphoid tumor-bearing mice and the occurrence of metastasis was studied after combined modality treatment with hyperthermia and X-irradiation. P388 ascites tumor cells were treated at 42 degrees C or 43.5 degrees C for 1 hr in vitro and transplanted on B6D2F1 mice intraperitoneally (i.p.) or intramuscularly (i.m.). Hyperthermic treatment at 43.5 degrees C increased the median survival time (MST). Increased life-span (ILS) was found after i.p. transplantation (54%) and after i.m. transplantation (30%). During the life-span of tumor-bearing animals, significantly fewer metastases were observed in liver and spleen after hyperthermia and 5-10% metastasis occurred after transplantation of ascites tumor cells treated at 43.5 degrees C in vitro compared with 90% in the untreated control animals. The lower occurrence of metastasis could not be ascribed to the higher cell-killing effect of hyperthermia. When both modalities were combined the best tumor growth retardation effect was obtained when ascites tumor cells were treated at 43.5 degrees C for 1 hr before being transplanted i.m. and 1 day later locally X-irradiated with 6 Gy. In this case, 77% ILS was found demonstrating a synergistic effect of the two modalities. While X-irradiation alone did not change the occurrence of metastasis, after combined modality treatment it was as low as with hyperthermia alone (5-10%). In connection with the significantly lower occurrence of metastasis, the possible alterations of P388 tumor cell membrane and surface proteins induced by in vitro hyperthermic treatment are discussed.
Frédéric Joliot-Curie' National Research Institute for Radiobiology and Radiohygiene, Budapest, Hungary.
L
L
Perlaky
A
A
Fónagy
E
E
Unger
E J
EJ
Hidvégi
D000818:Animals; D002470:Cell Survival / Q000528:radiation effects; D003131:Combined Modality Therapy; D006358:Hot Temperature / Q000627:therapeutic use*; D007941:Leukemia P388 / Q000473:pathology / Q000532:radiotherapy / Q000628:therapy*; D007942:Leukemia, Experimental / Q000628:therapy*; D051379:Mice; D009362:Neoplasm Metastasis